[PDF] Top 20 El incumplimiento en los contratos de obra pública
Has 10000 "El incumplimiento en los contratos de obra pública" found on our website. Below are the top 20 most common "El incumplimiento en los contratos de obra pública".
Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects
... PK interaction. The mean difference between treatments was back-transformed to calculate the geometric mean ratios (GMRs) and 90% confidence intervals (CIs) for the ...τ,ss between the treatments ... See full document
7
Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
... This study shows that cilnidipine and valsartan do not exert a significant PK drug interaction when coadministered in healthy male subjects. The evidence is that the point esti- mates of the ... See full document
5
Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
... potential pharmacokinetic and pharmacodynamic interactions between evogliptin and ...36 healthy male subjects. All subjects received three treatments, separated by 7-day ... See full document
7
<p>Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects</p>
... Only male subjects were recruited in this study due to practical reasons, mainly that recruiting and assigning separate hospital wards for female participants were dif fi cult in the current research ...in ... See full document
14
Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the <em>SLCO1B1</em> or <em>CYP2C9</em> genetic polymorphism affect these drug interactions?
... the pharmacokinetic (PK) interactions between these two drugs in healthy males and to explore the effect of SLCO1B1 and CYP2C9 polymorphisms on their interactions in two randomized, open-label ... See full document
28
Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
... DDI between fimasartan and ...drug interaction study between fimasartan and rosuvastatin in healthy ...of rosuvastatin changed by Table 1 Pharmacokinetic parameters of ... See full document
28
Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
... Purpose: Rosuvastatin is a synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor that effectively reduces low-density lipoprotein cholesterol ...hypercholesterolemia. Ezetimibe, a selective ... See full document
14
A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
... For rosuvastatin and N-des- methyl rosuvastatin, the extracted upper organic phase of samples was filtered with a ...N-desmethyl rosuvastatin, and ... See full document
6
Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
... following: subjects were to remain at the center for ≥ 72 h after dosing; alcohol-containing beverages and grapefruit-containing prod- ucts were not permitted from 3 days before dosing through Day 4; and ... See full document
10
No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects
... nistration were estimated to be 1.25 to 1.43, 1.23 to 1.40, and 1.27 to 1.42, respectively [14]. Similarly, in the VIKING-3 and−4 studies, integrase-resistant, HIV- infected patients received 50 mg of DTG twice daily, ... See full document
146
PHARMACODYNAMIC AND PHARMACOKINETIC DRUG INTERACTION OF GLIMEPIRIDE AND IRBESARTAN IN ANIMAL MODELS
... A group of six albino rats weighing between 180-250 g were administered with 2.7mg/200gm body weight of irbesartan and to another group of six albino rats glimepiride of 40µg/200gm body weight was administered ... See full document
15
Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model
... Regarding the nomogram, as a result of applying the equations of our exposed mathematical model, based on changes of the reaction velocity of ATZ versus that of BIL, with the implicated enzyme UGT1A1, we obtained a rela- ... See full document
15
Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers
... IFN-receptor interaction that triggers strong antiproliferative activities is desired in the cancer treatment with this ...non-optimal interaction with its ...effective interaction with its ... See full document
52
Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers
... The study reported here investigated the potential for a phar- macokinetic interaction between udenafil and dapoxetine in healthy male subjects. In the study, a 200 mg dose of udenafil ... See full document
5
<p>Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects</p>
... 12 subjects who were administered at least one dose of study drug ...the subjects who received the FDC formulation (n=59), three of them were evaluated as unrelated to the study drug (tendonitis, ... See full document
28
No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects
... while the column temperature was maintained at 30 ° C ± 5 ° C. The standards for amlodipine and the IS, amlo- dipine_d4 maleic acid salt, were provided by Hana Pharam Co., Ltd (Seoul, Korea) and Toronto Research ... See full document
24
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
... three subjects, and dizziness and pharyngolaryngeal pain, each reported in two ...two subjects, one of whom discontinued the study before the start of apixaban ... See full document
5
<p>A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers</p>
... all subjects who received at least one or more doses of fi masartan and/or linagliptin, safety was assessed through- out the study period by evaluating any undesirable signs, symptoms, or medical conditions ... See full document
5
PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION STUDY OF CURCUMIN WITH REPAGLINIDE IN NORMAL AND DIABETIC RATS
... dose interaction studies and Group IV administered orally with curcumin (80 mg/kg PO) for 7 days and on 8 th day curcumin (80 mg/kg PO) followed by repaglinide ... See full document
33
Evaluation of bio-equivalence and bio availability of levetiracetam 1000 mg tablet with reference to standard 1000 mg tablet in normal male in human healthy volunteers
... normal male healthy volunteers under fasting conditions The study will be carried out in accordance with the provisions of the current versions of the ICH Guidance for good clinical practices ICMR guidance ... See full document
12
Related subjects